FDA: Secukinumab Approved for Hidradenitis Suppurativa
Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Triple-Combination, Fixed-Dose Acne Gel Shows Promise as Treatment
The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.